Market Outlook

By 2035, the U.S. Diagnostic Imaging Devices Market is expected to reach approximately USD 27.36 billion, expanding at a CAGR of 6.30% during the forecast period 2026–2035. The market was valued at USD 14.85 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions. The estimate reflects revenue from new diagnostic imaging systems, modality-specific hardware, factory-integrated software, major upgrades, probes, detectors, coils, workstations, and selected mobile imaging platforms. It excludes radiology professional fees, routine imaging services, stand-alone enterprise PACS revenue, contrast media, radiopharmaceuticals, and therapeutic radiation systems.

The U.S. diagnostic imaging devices industry is a foundational clinical infrastructure market rather than a discretionary technology category. Imaging equipment is embedded in emergency care, cancer diagnosis, cardiovascular workups, neurological assessment, trauma triage, orthopedic evaluation, women’s health, surgical planning, and chronic disease management. The United States has one of the world’s highest concentrations of advanced imaging capacity, with approximately 86 CT, MRI, and PET systems per million residents on a combined basis. Applied to the current population base, this indicates an installed pool approaching 30,000 advanced scanners before accounting for general radiography, fluoroscopy, mammography, ultrasound, mobile C-arms, and point-of-care ultrasound devices.

The demand environment is supported by a large and aging patient population, high chronic disease prevalence, and exceptional imaging intensity across U.S. care pathways. The population aged 65 years and older reached 61.2 million in 2024 and represented 18.0% of the country. Older adults require disproportionately more CT, MRI, ultrasound, nuclear imaging, bone imaging, and mammography because cancer, stroke, cardiovascular disease, neurodegenerative disorders, and musculoskeletal conditions rise sharply with age. The American Cancer Society estimated more than 2.04 million new cancer diagnoses in 2025, while more than 795,000 strokes occur annually. These disease volumes sustain both high-throughput scanning and replacement demand for clinically advanced systems.

The historical market expanded from approximately USD 11.25 billion in 2021 to USD 13.82 billion in 2024. Growth during this period reflected recovery in hospital capital budgets, normalization of elective imaging volumes, accelerated replacement of aging scanners, adoption of digital radiography and 3D mammography, and investment in AI-enabled reconstruction and workflow software. The market reached USD 14.85 billion in 2025 as health systems restarted deferred projects, expanded outpatient imaging networks, and prioritized equipment that could increase scan capacity despite persistent shortages of radiologists, technologists, nurses, and medical physicists.

From 2026 through 2035, revenue growth will increasingly come from higher-value system replacement rather than simple unit expansion. Hospitals are evaluating photon-counting and spectral CT, helium-light or virtually helium-free MRI, wide-bore platforms, faster gradient systems, automated ultrasound, digital PET, mobile CT, advanced women’s imaging, and enterprise-connected imaging fleets. The strongest commercial propositions will combine diagnostic quality with measurable reductions in scan time, repeat imaging, radiation exposure, contrast use, staffing burden, energy consumption, downtime, and total cost of ownership.

 

Introduction

According to the U.S. Diagnostic Imaging Devices Market Report, the market is shaped by the interaction of clinical necessity, high capital intensity, reimbursement discipline, technology obsolescence, and hospital network consolidation. Imaging equipment is purchased through complex committees that typically include radiology leadership, service-line physicians, biomedical engineering, information technology, finance, supply chain, facilities management, and executive capital planning. A product must therefore satisfy more than image-quality expectations. It must fit the institution’s installed software architecture, room constraints, cybersecurity standards, service model, staffing capabilities, throughput targets, and reimbursement profile.

The U.S. market contains more than 5,100 community hospitals, over 900,000 staffed hospital beds, and more than 34 million annual hospital admissions. It also includes thousands of freestanding imaging centers, orthopedic and cardiology practices, oncology networks, urgent care sites, women’s imaging facilities, ambulatory surgery centers, and physician offices. The mammography segment alone operates through roughly 9,000 certified facilities and more than 26,000 accredited units, demonstrating the scale and distributed nature of imaging infrastructure outside major tertiary hospitals. This broad site base creates a balanced market comprising premium academic systems, enterprise-standardized hospital fleets, mid-tier community platforms, and compact devices designed for decentralized care.

Diagnostic imaging is not a single equipment cycle. X-ray and ultrasound are high-volume and widely distributed; CT and MRI carry higher capital values and longer planning cycles; nuclear imaging depends on specialized clinical programs and tracer availability; mammography operates within a tightly regulated quality framework; and mobile imaging serves emergency, intensive care, operating room, neonatal, and rural access needs. Product lifecycles therefore vary by modality, software upgradability, detector performance, serviceability, and clinical relevance. A seven- to twelve-year replacement pattern is common for major modalities, but fleet age can extend when budgets are constrained or when a system remains serviceable through software, coil, detector, or workstation upgrades.

The market is increasingly defined by enterprise fleet strategy. Large integrated delivery networks may operate dozens or hundreds of imaging systems across hospitals and outpatient sites. They seek common user interfaces, harmonized protocols, predictable service performance, central dose monitoring, remote system support, cybersecurity updates, and standardized image quality. Vendors that can offer multiyear technology road maps, flexible financing, managed equipment arrangements, and fleet-level analytics have a competitive advantage over suppliers selling isolated scanners.

This report evaluates five primary segmentations: product type, clinical application, end user, portability, and technology architecture. The market outlook is designed for manufacturers, component suppliers, software developers, investors, health systems, distributors, and strategic planners assessing where U.S. imaging demand will concentrate. The central commercial question is not simply how many scans will be performed. It is which modalities, configurations, and procurement models will receive capital approval as hospitals attempt to manage rising demand with constrained labor and tighter operating margins.

 

Key Market Drivers: What’s Fueling the U.S. Diagnostic Imaging Devices Market Boom?

The first driver is the expanding clinical burden that depends on imaging for diagnosis, staging, treatment selection, and follow-up. More than 2.04 million new cancer cases were expected in the United States in 2025, creating substantial demand for CT, MRI, PET/CT, SPECT/CT, ultrasound, mammography, and image-guided biopsy workflows. Cancer imaging is recurring rather than episodic because patients often require baseline evaluation, staging, treatment-response assessment, surveillance, and recurrence monitoring. This makes oncology one of the most durable sources of advanced imaging utilization and creates strong demand for quantitative, reproducible, multi-modality platforms.

The second driver is population aging. The U.S. population aged 65 and older reached 61.2 million in 2024 and grew much faster than the working-age population between 2020 and 2024. Aging increases the incidence of stroke, dementia, cancer, osteoarthritis, osteoporosis, spinal disease, valvular disease, and abdominal disorders. It also raises the operational need for patient-friendly imaging systems with wider bores, lower table heights, faster protocols, motion correction, metal-artifact reduction, and safer scanning of medically complex patients. States such as Florida, Maine, West Virginia, Pennsylvania, Delaware, Hawaii, and Vermont have especially high shares of older residents and therefore represent important replacement and capacity-expansion markets.

The third driver is the replacement of an aging installed base. Many U.S. hospitals deferred equipment upgrades during the pandemic and subsequent inflationary period. Extended use can be economically rational, but older scanners may have lower throughput, limited cybersecurity support, higher energy consumption, greater service costs, or insufficient compatibility with advanced reconstruction and AI applications. Replacement decisions are increasingly triggered when the total cost of downtime, staffing inefficiency, and lost referrals exceeds the annualized cost of a new system. Vendors that quantify these economics can accelerate capital approval.

The fourth driver is the movement of imaging into outpatient and decentralized settings. High-deductible health plans, payer site-of-care policies, patient convenience, and health-system network strategies are supporting freestanding imaging centers and community-based sites. Outpatient facilities often require equipment with lower acquisition costs, compact footprints, simplified siting, predictable uptime, and high daily utilization. At the same time, hospitals are moving portable ultrasound, mobile radiography, compact CT, and mobile C-arms closer to bedsides and procedure rooms to reduce patient transport and improve clinical turnaround.

The fifth driver is labor scarcity. Imaging departments face shortages of radiologists, technologists, sonographers, nurses, schedulers, and medical physicists. Labor constraints strengthen the business case for automated patient positioning, protocol selection, scan planning, image reconstruction, quality checks, triage, reporting assistance, and remote operations. A new scanner that produces similar clinical quality but reduces room time by several minutes can create substantial enterprise value when multiplied across thousands of annual examinations. Workflow automation is therefore becoming a core procurement criterion rather than an optional software feature.

The sixth driver is the expansion of AI-enabled imaging. The FDA’s authorized AI-enabled medical device list is led by radiology applications, reflecting the availability of standardized digital images and high-value use cases. AI is being integrated into acquisition, reconstruction, denoising, segmentation, lesion detection, quantitative measurement, exam prioritization, and report preparation. The revenue impact extends beyond stand-alone software because hospitals increasingly prefer scanners that are designed to support AI at the console and across the enterprise. This raises the value of computing hardware, cloud connectivity, and upgradeable software architectures.

The seventh driver is regulatory and quality standardization. The federal breast density notification requirement became effective in September 2024, creating a national framework for communicating breast density after mammography. This supports clinical discussion of supplemental imaging for appropriate patients and strengthens demand for digital breast tomosynthesis, breast ultrasound, contrast-enhanced mammography, and breast MRI. Radiation dose standards, accreditation requirements, quality reporting, and cybersecurity expectations also favor modern systems with automated documentation and protocol governance.

The eighth driver is hospital capital procurement behavior. Imaging departments influence emergency throughput, surgical readiness, oncology referrals, stroke certification, cardiovascular programs, and physician recruitment. Health systems therefore protect imaging investments when equipment has a clear role in strategic service lines. However, approvals are increasingly tied to return-on-investment models that include scan volume, reimbursement, contribution margin, staffing, maintenance, room renovation, power and cooling, contrast utilization, and referral leakage. Manufacturers that provide credible site-specific economic modeling are likely to gain share.

The ninth driver is greater use of imaging for minimally invasive procedures. Diagnostic and interventional workflows increasingly converge around CT, ultrasound, fluoroscopy, mobile C-arms, cone-beam CT, and hybrid operating room systems. Although this report excludes most therapeutic devices, the imaging platforms that guide biopsies, drainage, vascular access, orthopedic fixation, pain procedures, and structural interventions remain within the addressable device ecosystem. Hospitals value platforms that can support both diagnosis and image-guided procedures because they improve asset utilization and service-line flexibility.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. diagnostic imaging devices market is shifting from incremental image-quality improvement toward integrated gains in diagnostic confidence, throughput, patient experience, and lifecycle economics. The most important platforms are not necessarily those with the highest technical specifications. They are the systems that translate technical performance into fewer repeat scans, shorter appointments, lower radiation or contrast exposure, easier operation, reduced downtime, and more consistent results across a distributed workforce.

Photon-counting CT is one of the most consequential innovation cycles. Unlike conventional energy-integrating detectors, photon-counting systems measure individual X-ray photons and their energy characteristics. This can improve spatial resolution, spectral information, and dose efficiency. FDA clearance of an expanded photon-counting CT class in 2025 signaled broader U.S. commercialization beyond a single flagship platform. Over the forecast period, adoption is expected to move from academic and high-acuity institutions into large regional systems, particularly for cardiac imaging, oncology, lung disease, musculoskeletal imaging, and complex cases where high resolution can change management.

Spectral CT is also moving toward broader routine use. Detector-based and source-based spectral approaches can help characterize materials, reduce artifacts, support virtual non-contrast reconstructions, and improve evaluation of vascular, oncologic, and emergency conditions. The commercial advantage is strongest when spectral information is available without requiring a separate patient selection decision. As newer platforms integrate AI-powered reconstruction and automated post-processing, spectral data can become part of normal workflow rather than a specialized research capability.

MRI innovation is focused on speed, access, sustainability, and ease of operation. Deep-learning reconstruction and compressed sensing can shorten scans or improve image quality at similar scan times. Wider bores, lower table heights, quieter sequences, motion correction, and simplified setup improve patient tolerance. Virtually helium-free and low-helium magnet designs reduce exposure to helium supply risk and can simplify siting. Higher-gradient systems and specialized neuro, cardiac, and musculoskeletal platforms are creating premium niches, while mid-field and compact MRI systems are expanding access in outpatient, emergency, and specialty settings.

Ultrasound is undergoing one of the broadest distribution shifts. Premium cart-based systems remain essential in radiology, cardiology, obstetrics, and vascular care, but handheld and ultraportable devices are extending imaging to emergency departments, intensive care units, primary care, anesthesiology, hospital medicine, and home-based services. AI-assisted measurements, anatomy recognition, probe guidance, and quality feedback can reduce operator variability. The long-term market opportunity depends on whether vendors can integrate these devices into credentialing, documentation, billing, image storage, and enterprise governance rather than treating them as disconnected tools.

Digital radiography is advancing through wireless detectors, automated positioning, low-dose protocols, image stitching, and mobile workflow. General X-ray remains the highest-volume imaging category in many hospitals and is often the first modality used in emergency and inpatient care. New mobile systems improve bedside imaging in intensive care, neonatal, isolation, and postoperative environments. Detector durability, battery life, disinfection, cybersecurity, and fleet tracking are increasingly important because large health systems may manage hundreds of portable detectors across multiple sites.

Women’s imaging innovation is expanding beyond replacement mammography. Digital breast tomosynthesis is now widely deployed, while contrast-enhanced mammography, automated breast ultrasound, AI-based interpretation support, breast density assessment, and abbreviated MRI protocols are creating additional pathways. The federal breast density reporting requirement increases the importance of patient communication and supplemental risk assessment. Vendors that connect acquisition, interpretation, risk stratification, and patient navigation can offer greater value than equipment-only providers.

Nuclear imaging is moving toward digital detectors, improved time-of-flight performance, total-body and long-axial-field-of-view PET, advanced SPECT/CT, and more quantitative workflows. Growth is linked to oncology, neurology, cardiology, and theranostics. The device opportunity is strengthened by expanding radiopharmaceutical pipelines, but purchasing decisions depend on tracer supply, reimbursement, patient volumes, shielding, staffing, and the institution’s strategic commitment to molecular imaging. High-sensitivity systems that reduce scan time or tracer dose may materially improve economics.

Manufacturers are also raising the bar through remote operations and fleet intelligence. Centralized command centers can support protocol standardization, remote scanning assistance, and cross-site coverage. Predictive maintenance can identify component deterioration before failure, while usage analytics can reveal underutilized capacity. These capabilities are highly relevant to integrated delivery networks that operate rural and community sites but struggle to recruit experienced technologists. The winning commercial model will combine equipment, software, service, and operational support without creating excessive vendor lock-in.

Cybersecurity and interoperability have become product-design requirements. Imaging systems are networked computing environments that may remain installed for a decade or longer. Health systems expect secure software updates, vulnerability management, auditability, identity controls, and compatibility with DICOM, HL7, FHIR, enterprise viewers, and cloud platforms. Vendors that fail to maintain cybersecurity support can shorten the economically useful life of otherwise functional equipment. Conversely, upgradeable architectures can extend customer relationships and generate recurring revenue.

 

Segmentation Insights

The U.S. Diagnostic Imaging Devices Market is segmented on the basis of product type, application, end user, portability, and technology architecture. The segment structure reflects the way U.S. providers budget, deploy, and evaluate imaging assets. Each modality has a distinct clinical role, capital profile, replacement cycle, and competitive landscape.

 

By Product Type

X-ray and Fluoroscopy Systems
X-ray and fluoroscopy systems represent the largest installed-base segment because they are used across hospitals, urgent care centers, orthopedic practices, emergency departments, dental and surgical settings, and mobile bedside workflows. The segment includes fixed digital radiography rooms, mobile radiography systems, fluoroscopy suites, mobile C-arms, and digital detectors. Revenue is supported by detector replacement, room modernization, wireless conversion, and demand for lower-dose imaging. Mobile C-arms and fluoroscopy benefit from growth in orthopedic, pain, gastrointestinal, urology, vascular, and minimally invasive procedures. Competitive differentiation is increasingly based on automation, detector quality, maneuverability, dose management, and service reliability.

Computed Tomography Systems
Computed tomography is one of the highest-value and most strategically important segments. CT is central to emergency medicine, stroke, trauma, lung imaging, cardiac assessment, oncology, abdominal diagnosis, and surgical planning. The segment includes conventional multi-slice CT, dual-source CT, spectral CT, photon-counting CT, cardiac CT, mobile CT, and specialized systems. U.S. hospitals prioritize high throughput, rapid reconstruction, low-dose performance, motion management, and ease of protocol standardization. Premium growth will be led by photon-counting and spectral platforms, while community hospitals and outpatient centers will continue to purchase cost-efficient systems with strong service support.

Magnetic Resonance Imaging Systems
MRI generates substantial revenue because of high system values, room-construction requirements, coils, software packages, and service intensity. The segment includes 1.5T and 3T systems, specialized high-field systems, open and wide-bore MRI, compact and mid-field platforms, and mobile MRI. Demand is strongest in neurology, musculoskeletal care, oncology, cardiology, women’s health, and pediatrics. Replacement is driven by scan speed, patient comfort, helium management, energy use, AI-enabled reconstruction, and advanced applications. The outpatient market favors dependable 1.5T and efficient 3T systems, while academic centers invest in premium platforms for complex diagnostics and research.

Ultrasound Systems
Ultrasound is a broad and fast-evolving segment that includes premium cart-based systems, compact systems, handheld devices, probes, and application-specific platforms. It serves radiology, cardiology, obstetrics and gynecology, vascular imaging, emergency medicine, anesthesiology, surgery, and primary care. Growth is supported by portability, lack of ionizing radiation, lower capital cost, and expanding point-of-care use. Premium systems compete on image quality and advanced quantification, while handheld systems compete on usability, connectivity, subscription economics, and AI guidance. Probe replacement and specialty transducers create recurring revenue.

Nuclear Imaging and PET/SPECT Systems
Nuclear imaging includes PET, PET/CT, PET/MRI, SPECT, and SPECT/CT systems. It is a smaller installed-base category but carries high strategic value in oncology, neurology, cardiology, and theranostics. Digital detectors, improved sensitivity, longer axial fields of view, and quantitative software are increasing system productivity. The U.S. opportunity is concentrated in academic centers, oncology networks, major hospital systems, and specialty imaging providers. Capital decisions are tightly linked to radiopharmaceutical access, reimbursement, shielding requirements, referral volume, and the ability to support emerging diagnostic and therapeutic isotopes.

Mammography and Breast Imaging Systems
Mammography and breast imaging form a regulated, recurring screening market. The segment includes 2D digital mammography, digital breast tomosynthesis, contrast-enhanced mammography, breast biopsy systems, automated breast ultrasound, and dedicated breast imaging software. Approximately 9,000 certified U.S. mammography facilities operate more than 26,000 accredited units, creating a large replacement base. Federal breast density notification requirements are increasing awareness of supplemental imaging. Growth will be strongest in tomosynthesis upgrades, AI-enabled detection, workflow integration, and multimodality breast centers.

 

By Application

Oncology Imaging
Oncology is the largest high-value application because imaging is used throughout screening, diagnosis, staging, biopsy guidance, treatment planning, response assessment, and surveillance. CT and MRI provide anatomical detail, PET provides metabolic information, ultrasound supports targeted evaluation, and mammography is central to breast screening. More than 2.04 million new U.S. cancer cases in 2025 demonstrate the scale of the patient pool. Growth is reinforced by precision medicine and theranostics, which require quantitative and reproducible imaging across multiple time points.

Cardiovascular Imaging
Cardiovascular imaging includes cardiac CT, cardiac MRI, echocardiography, nuclear cardiology, vascular ultrasound, and fluoroscopy-supported diagnostics. Demand is supported by coronary disease, heart failure, valvular disease, arrhythmias, and vascular conditions. Cardiac CT is gaining importance because of faster scanners, improved motion correction, spectral capabilities, and expanding clinical evidence. Echocardiography remains the largest-volume cardiovascular modality, while PET and SPECT support perfusion and viability assessment. Health systems value platforms that integrate with cardiology reporting and procedure planning.

Neurology Imaging
Neurology is a major growth application because stroke, dementia, multiple sclerosis, epilepsy, brain tumors, and traumatic brain injury require advanced imaging. More than 795,000 strokes occur annually in the United States, making rapid CT and MRI access essential for treatment selection. The segment benefits from high-speed CT, perfusion imaging, diffusion MRI, vessel imaging, automated stroke triage, and quantitative neuroimaging. Academic centers also invest in PET and advanced MRI for dementia and movement-disorder evaluation.

Orthopedic and Musculoskeletal Imaging
Orthopedic and musculoskeletal imaging is a high-volume application across hospitals, orthopedic groups, sports medicine practices, urgent care centers, and ambulatory surgery centers. Digital radiography is the first-line modality, while MRI supports soft-tissue, joint, spine, and sports-injury assessment. CT and cone-beam CT are used for complex bone anatomy and surgical planning. Growth is supported by aging, obesity, joint degeneration, sports injuries, and outpatient orthopedic expansion. Compact MRI, weight-bearing CT, and low-dose imaging can differentiate specialty providers.

Women’s Health Imaging
Women’s health applications include breast imaging, obstetric ultrasound, gynecologic ultrasound, pelvic MRI, bone density assessment, and selected CT procedures. Mammography has a large recurring screening base, and approximately 80% of eligible U.S. women are screened for breast cancer according to comparative health-system data. The shift toward density-informed care supports supplemental ultrasound and MRI for selected patients. Women’s imaging centers prioritize patient experience, rapid reporting, navigation, and coordinated biopsy workflows.

Emergency, Trauma, and Acute Care Imaging
Emergency and acute care are among the most throughput-sensitive applications. CT is essential for stroke, trauma, abdominal pain, pulmonary embolism, and acute neurological symptoms. Mobile radiography and ultrasound reduce transport from intensive care and emergency departments. Imaging systems in this application are evaluated on speed, uptime, ease of use, and 24-hour service support. Compact CT, portable ultrasound, and AI-based exam prioritization are particularly relevant to rural hospitals and facilities without continuous subspecialty coverage.

 

By End User

Hospitals and Integrated Health Systems
Hospitals and health systems are the dominant end users by value. They purchase premium CT, MRI, nuclear imaging, fluoroscopy, mobile radiography, mammography, and enterprise ultrasound fleets. Large systems standardize vendors to improve training, service, protocol consistency, and contracting leverage. Capital committees evaluate imaging projects against service-line growth, emergency throughput, inpatient demand, referral retention, and replacement risk. System-affiliated community hospitals represent most U.S. hospital capacity, giving enterprise contracts substantial influence over market share.

Diagnostic Imaging Centers
Freestanding and health-system-owned imaging centers are important buyers of CT, MRI, ultrasound, mammography, and X-ray systems. Their economics depend on high utilization, predictable reimbursement, patient scheduling, and referral relationships. They favor equipment with efficient room turnover, compact footprints, reliable uptime, and lower operating costs. Independent centers may use refurbished or value-tier systems, while large networks increasingly invest in premium platforms to differentiate on speed, subspecialty capability, and patient experience.

Specialty Clinics and Ambulatory Surgery Centers
Orthopedic clinics, cardiology practices, women’s health centers, oncology clinics, urology centers, and ambulatory surgery centers purchase application-specific imaging. Common assets include ultrasound, digital X-ray, mini C-arms, mobile C-arms, cone-beam CT, and compact MRI. The segment grows as procedures and diagnostics shift outside hospitals. Buyers prioritize ease of operation, rapid installation, financing flexibility, and compatibility with specialty workflow. Vendors must demonstrate that equipment can generate sufficient procedure volume without imposing hospital-level complexity.

Physician Offices, Urgent Care, and Point-of-Care Settings
Physician offices and urgent care centers support demand for digital radiography, ultrasound, and handheld imaging. Point-of-care ultrasound is expanding in primary care, emergency medicine, hospital medicine, anesthesia, and home-based services. The commercial opportunity is large but fragmented. Adoption depends on training, credentialing, documentation, reimbursement, and integration with electronic health records. Subscription and software models may lower initial barriers, but health systems require governance to avoid uncontrolled device proliferation.

Academic, Government, and Research Institutions
Academic medical centers, Veterans Health Administration facilities, Department of Defense sites, and research institutions are strategically important early adopters. They purchase advanced CT, MRI, PET, and hybrid systems, participate in clinical trials, and influence national practice. Procurement can be slower because of public contracting and research requirements, but these institutions provide reference sites and evidence generation. High-field MRI, photon-counting CT, quantitative PET, and advanced neuroimaging are especially concentrated in this segment.

 

By Portability

Fixed Imaging Systems
Fixed systems account for the largest market share because CT, MRI, PET, SPECT, fluoroscopy, mammography, and most radiography rooms require dedicated space and infrastructure. Fixed systems offer the highest throughput and technical performance. Their economics include room construction, shielding, power, cooling, magnet siting, and service access. Replacement projects can take months or years, making early capital planning and vendor project management critical.

Mobile and Transportable Systems
Mobile systems include portable radiography, mobile C-arms, trailer-based CT and MRI, mobile mammography, and transportable imaging platforms. They are used to extend capacity, support construction periods, serve rural communities, and bring imaging to operating rooms or bedsides. Demand increased as hospitals sought to reduce patient movement and manage infection-control requirements. Fleet management, battery performance, maneuverability, and service response are central buying criteria.

Handheld and Point-of-Care Systems
Handheld systems are led by ultrasound but also include compact imaging and visualization tools. Their lower cost and portability can expand access, but clinical value depends on operator skill and workflow integration. AI-based acquisition guidance, automated measurements, secure cloud storage, and device management are improving scalability. The fastest growth will occur where organizations build structured point-of-care ultrasound programs rather than relying on isolated individual purchases.

 

By Technology Architecture

Digital and Software-Upgradeable Platforms
Digital platforms dominate the market and include software-upgradeable scanners, digital detectors, advanced consoles, and application packages. The ability to add reconstruction algorithms, clinical applications, cybersecurity updates, and workflow tools can extend useful life and protect capital investment. Buyers increasingly ask vendors to disclose upgrade paths at the time of purchase. Closed architectures may offer optimized performance but can create long-term cost and interoperability concerns.

AI-Enabled Imaging Systems
AI-enabled systems integrate algorithms into acquisition, reconstruction, quality control, triage, quantification, and reporting. Radiology is the largest category on the FDA’s AI-enabled device list, demonstrating the maturity of imaging use cases. Hospitals prefer validated tools that reduce measurable workload and fit existing workflows. Commercial success depends on clinical evidence, monitoring, cybersecurity, reimbursement relevance, and the ability to manage multiple algorithms across enterprise fleets.

Spectral, Photon-Counting, and Advanced Detector Technologies
Advanced detector technologies are creating a premium replacement cycle in CT, nuclear imaging, digital radiography, and mammography. Photon-counting and spectral CT can provide new diagnostic information and improved dose efficiency. Digital PET detectors increase sensitivity and timing performance. Higher-performance flat-panel detectors improve X-ray and fluoroscopy quality. These technologies command premium pricing when they enable new clinical pathways or materially improve throughput.

Hybrid and Quantitative Imaging Platforms
Hybrid platforms combine anatomical and functional information through PET/CT, SPECT/CT, PET/MRI, and selected fusion-imaging configurations. Quantitative software supports oncology response assessment, neurology, cardiology, and theranostics. These systems are capital intensive and concentrated in high-volume institutions, but their strategic relevance is increasing as targeted radiopharmaceuticals expand. Vendor competitiveness depends on detector performance, workflow, quantification, and integration with treatment planning.

Cloud-Connected and Enterprise-Orchestrated Imaging
Cloud-connected imaging links scanners with protocol libraries, remote support, fleet analytics, AI orchestration, and enterprise viewing. This architecture is important for multihospital systems and distributed outpatient networks. It can reduce variation and support remote expertise, but requires strong cybersecurity and data governance. Vendors that provide open integration and transparent data access will be better positioned than those that rely on restrictive proprietary ecosystems.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Diagnostic Imaging Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, hospital density, chronic disease burden, concentration of academic centers, outpatient imaging penetration, payer mix, and state capital-investment patterns. The South represented the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the most technology-intensive region on a per-facility basis, and the Midwest provides a large, stable replacement base.

 

South

The South was the largest regional market, valued at approximately USD 5.35 billion in 2025, and is projected to reach about USD 9.96 billion by 2035 at a CAGR of approximately 6.41%. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas, as well as the District of Columbia. Its leadership is supported by population scale, rapid metro growth, high chronic disease burden, expanding hospital systems, and a large base of outpatient imaging facilities.

Texas is the region’s largest state market and one of the most important imaging markets nationally. Houston, Dallas–Fort Worth, Austin, and San Antonio support major academic centers, large integrated delivery networks, oncology programs, trauma centers, and freestanding imaging operators. The state’s population growth creates demand for new capacity, while its broad rural geography supports mobile imaging, teleradiology-enabled workflows, and compact systems. Texas is especially attractive for CT, MRI, ultrasound, women’s imaging, and mobile C-arm vendors because health systems are expanding across both high-growth suburbs and regional hubs.

Florida is a high-value imaging market because of its large older population and strong demand for oncology, neurological, cardiovascular, musculoskeletal, and women’s imaging. The state supports substantial MRI, CT, PET, mammography, and ultrasound volumes across hospital systems and outpatient centers. Population migration into central and southwest Florida is creating new capital projects, while hurricane exposure increases the importance of resilient service networks and mobile capacity. Florida’s mature Medicare mix also makes reimbursement and operational efficiency central to purchasing decisions.

North Carolina, Georgia, Tennessee, Virginia, and Maryland are major growth markets. North Carolina combines fast population growth with academic centers and expanding systems in the Research Triangle, Charlotte, and the Triad. Georgia is led by Atlanta’s referral networks and suburban expansion. Tennessee has strong healthcare-system headquarters, oncology networks, and regional referral centers in Nashville, Memphis, Knoxville, and Chattanooga. Virginia and Maryland benefit from dense provider markets, federal institutions, and advanced academic programs. These states are important early adopters of enterprise imaging, AI, and outpatient fleet standardization.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have meaningful imaging demand linked to high rates of cancer, stroke, obesity, diabetes, and cardiovascular disease. Their market opportunity is divided between premium systems in urban referral centers and access-oriented platforms in rural communities. Mobile radiography, portable ultrasound, value-tier CT, and regional service support are especially important. West Virginia and Kentucky also have older and medically complex populations, strengthening demand for neurological, pulmonary, and musculoskeletal imaging.

Delaware and the District of Columbia are smaller by population but have high imaging intensity because of dense healthcare access and proximity to major regional systems. Across the South, the central strategic theme is scale: health systems are expanding networks, standardizing fleets, and shifting routine imaging into outpatient settings. The region is expected to retain the largest share through 2035 because population growth and disease burden will continue to support both new installations and replacement demand.

 

West

The West represented approximately USD 3.27 billion in 2025 and is expected to reach about USD 6.52 billion by 2035, reflecting the fastest regional CAGR of approximately 7.14%. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Growth is supported by population migration, technology adoption, strong academic systems, expanding outpatient networks, and a high concentration of digital health and medtech innovation.

California is the dominant state market in the West and a national center for imaging innovation. Its size, academic medical centers, integrated systems, oncology programs, and technology ecosystem support early adoption of photon-counting CT, advanced MRI, digital PET, AI-enabled imaging, and cloud-based workflow. The state also has a large and diverse population requiring extensive screening, emergency, and chronic disease imaging. Procurement is sophisticated and often tied to sustainability, cybersecurity, interoperability, and workforce productivity. High construction and labor costs increase demand for systems that maximize throughput within existing space.

Arizona and Nevada are among the fastest-growing state opportunities because of population expansion and aging. Phoenix, Tucson, Las Vegas, and Reno are adding hospital and outpatient capacity, supporting demand for CT, MRI, mammography, ultrasound, and orthopedic imaging. The climate and retirement migration patterns create high cardiovascular, oncology, and musculoskeletal imaging volumes. Vendors with strong service coverage and rapid installation capabilities can benefit as systems expand beyond established metropolitan centers.

Washington, Oregon, Colorado, and Utah have sophisticated integrated delivery networks and high adoption of enterprise digital tools. Seattle, Portland, Denver, Salt Lake City, and surrounding growth corridors are important markets for AI, advanced neuroimaging, cardiovascular imaging, and outpatient MRI. Colorado and Utah also benefit from population growth and strong specialty-care networks. These states are likely to adopt remote operations and cross-site protocol standardization as provider systems extend into mountain and rural communities.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller but strategically relevant access markets. Geographic dispersion creates a need for mobile imaging, compact CT, portable ultrasound, and remote support. Alaska and Hawaii face logistics and service challenges that can increase lifecycle costs, while rural Mountain West states depend on regional referral networks. Vendors that can guarantee uptime and provide remote diagnostics have an advantage. The West’s overall growth will be led by premium technology in coastal and major metro systems and access-oriented innovation in dispersed communities.

 

Northeast

The Northeast accounted for approximately USD 3.42 billion in 2025 and is projected to reach about USD 6.01 billion by 2035, expanding at a CAGR of approximately 5.80%. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, New Hampshire, Vermont, and Maine. It has the country’s highest regional median age and one of the densest concentrations of academic medical centers, subspecialty radiologists, cancer institutes, and research programs.

New York is the largest Northeast market. New York City supports globally recognized academic centers, high-acuity hospitals, cancer programs, and dense outpatient imaging networks. Upstate systems serve broad regional populations and require scalable service coverage. The state is important for premium MRI, CT, PET, women’s imaging, and enterprise imaging software. Capacity constraints and high real-estate costs favor high-throughput systems, compact room designs, and upgrades that extend existing infrastructure.

Pennsylvania and New Jersey provide large and diverse imaging markets. Philadelphia, Pittsburgh, and major suburban systems support advanced oncology, cardiovascular, neurological, and orthopedic imaging. New Jersey combines a dense insured population with extensive outpatient imaging. Both states have sizable older populations and strong health-system competition, which encourages technology differentiation. Replacement demand is substantial because many systems operate mature fleets across multiple hospitals and ambulatory sites.

Massachusetts and Connecticut are influential early-adoption markets. Boston’s academic ecosystem supports advanced MRI, PET, neuroimaging, AI validation, and clinical research. Connecticut has high healthcare utilization and proximity to New York and Boston referral networks. Rhode Island, New Hampshire, Vermont, and Maine are smaller markets but have older populations and important regional health systems. Maine and Vermont face rural access challenges, creating demand for mobile and remote-supported imaging alongside premium systems in tertiary centers.

The Northeast will grow more slowly than the West and South because population growth is modest and the installed base is mature. However, it will remain a high-margin region because of procedure complexity, research intensity, and willingness to adopt clinically differentiated technologies. Manufacturers often use Northeast academic centers as reference sites, training locations, and evidence-generation partners. Procurement is rigorous and requires strong clinical, technical, cybersecurity, and health-economic documentation.

 

Midwest

The Midwest represented approximately USD 2.81 billion in 2025 and is forecast to reach about USD 4.87 billion by 2035, reflecting a CAGR of approximately 5.65%. The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Kansas, Missouri, Nebraska, North Dakota, and South Dakota. It has a large established hospital base, major academic centers, significant chronic disease burden, and broad rural catchment areas that support durable replacement demand.

Illinois, Ohio, Michigan, and Minnesota are the largest state markets. Chicago supports a dense network of academic, community, oncology, and specialty providers. Ohio has major systems in Cleveland, Columbus, and Cincinnati, including nationally influential imaging and cardiovascular programs. Michigan supports high imaging demand across Detroit, Grand Rapids, and regional systems. Minnesota is strategically important because of its medtech ecosystem and concentration of advanced healthcare organizations. These states are key markets for enterprise fleet agreements and premium technology adoption.

Indiana, Wisconsin, and Missouri provide stable demand across large health systems, orthopedic networks, cancer centers, and community hospitals. Indianapolis, Milwaukee, Madison, St. Louis, and Kansas City are important imaging hubs. Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but have broad rural geographies and regional referral systems. Mobile imaging, remote operations, portable ultrasound, and dependable service are particularly important in these states.

The Midwest’s procurement environment is often highly value-conscious. Health systems seek proven performance, predictable service, and flexible capital structures. Refurbished systems and upgrades can compete effectively in smaller facilities, while large academic and tertiary centers continue to invest in photon-counting CT, advanced MRI, and digital PET. The region is not expected to gain national share, but its large installed base and orderly replacement cycles make it one of the most reliable markets for long-term vendor relationships.

 

Key Market Players

The U.S. Diagnostic Imaging Devices Competitive Landscape is moderately consolidated in major capital modalities and highly fragmented in portable imaging, specialty systems, and software. GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems USA, and Fujifilm Healthcare Americas compete across multiple high-value modalities and can offer enterprise contracts, financing, service, and fleet standardization. Hologic has a leading strategic position in women’s imaging, while specialized competitors are expanding in ultrasound, mobile CT, orthopedic imaging, AI, and point-of-care systems.

Competition is increasingly based on platform economics rather than scanner specifications alone. Health systems evaluate installed-base compatibility, service response, cybersecurity, software upgrades, training, remote support, financing, and long-term technology road maps. Broad suppliers can bundle equipment across radiology, cardiology, operating rooms, and outpatient sites. Focused suppliers can still win when they solve a high-priority workflow problem, offer a differentiated modality, or provide superior access economics.

Some of the key players in the U.S. Diagnostic Imaging Devices industry are:

GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems USA
Fujifilm Healthcare Americas
Hologic
Carestream Health
Samsung Healthcare and NeuroLogica
United Imaging Healthcare
Shimadzu Medical Systems USA
Konica Minolta Healthcare Americas
Esaote North America
Mindray North America
Agfa HealthCare
Sectra
Butterfly Network
Clarius Mobile Health
EchoNous
iCAD
Aidoc
Nanox
CurveBeam AI
Orthoscan
Ziehm Imaging
Planmeca USA

The leading vendors are investing heavily in advanced detector technology, AI-enabled reconstruction, remote operations, and enterprise software. Market share through 2035 will be influenced by the timing of replacement cycles, access to capital, service execution, clinical evidence, software monetization, and the ability to support health-system standardization. New entrants are most likely to gain share in compact MRI, handheld ultrasound, AI workflow, spectral imaging, and specialized orthopedic or point-of-care applications. Large incumbents will defend their position through installed-base upgrades, multiyear agreements, and integrated service models.

 

Recent Developments

Recent developments in the U.S. Diagnostic Imaging Devices Market demonstrate a shift toward advanced detector technologies, software-led workflow, and lower-infrastructure system design. In March 2025, Siemens Healthineers received FDA clearance for an expanded class of photon-counting CT scanners that included both dual-source and single-source configurations. This development is commercially important because it broadens the addressable market for photon-counting technology beyond a limited group of flagship academic installations and creates a new replacement benchmark for premium CT.

In 2026, Philips received U.S. clearance for a next-generation AI-powered detector-based spectral CT system. The platform reflects a broader competitive movement toward spectral information as a routine acquisition capability rather than an optional protocol. Spectral and photon-counting systems are likely to intensify CT replacement activity as hospitals compare clinical differentiation, dose efficiency, contrast reduction, workflow, and total cost of ownership.

MRI development is increasingly focused on helium independence and operational sustainability. New virtually helium-free 1.5T platforms and lower-helium magnet designs reduce exposure to helium supply, quench-management, and siting concerns. Manufacturers are also using AI to automate patient positioning, planning, reconstruction, and quality control. These features are especially relevant to community hospitals and outpatient centers that lack highly specialized MRI staff.

GE HealthCare completed its acquisition of MIM Software in April 2024, strengthening its imaging analytics, molecular imaging, radiation oncology, and workflow capabilities. The transaction illustrates the strategic value of software that connects multiple imaging modalities and clinical pathways. Large equipment vendors are increasingly acquiring or partnering with software companies to improve quantification, enterprise orchestration, and recurring revenue.

The updated Mammography Quality Standards Act requirements became enforceable in September 2024, including a federal breast density notification requirement. This regulatory change standardizes communication across states and supports broader discussion of supplemental imaging for appropriate patients. The commercial impact extends to digital breast tomosynthesis, breast ultrasound, contrast-enhanced mammography, breast MRI, AI-based risk assessment, and patient-navigation systems.

The FDA’s AI-enabled medical device list continued to expand through 2025 and 2026, with radiology remaining the largest lead panel. New clearances cover detection, segmentation, measurement, risk prediction, image enhancement, and acquisition guidance. The market is moving from single-algorithm purchases toward enterprise AI governance and modality-integrated tools. Hospitals are becoming more selective and are prioritizing algorithms that demonstrate measurable clinical or operational outcomes.

Portable and point-of-care ultrasound vendors are expanding AI guidance, automated measurements, and cloud connectivity. Adoption is moving beyond emergency and critical care into primary care, home services, and specialty practices. The next competitive phase will be determined by training, documentation, credentialing, reimbursement support, and enterprise integration. Devices that cannot be governed within health-system IT and clinical-quality frameworks may face slower scale despite attractive hardware.

Hospital financial pressure is also reshaping commercial models. Managed equipment services, subscription software, fleet replacement agreements, and refurbished systems are gaining attention as providers seek to preserve cash. Vendors are responding with multiyear technology plans and performance guarantees. These models can accelerate modernization but require careful contract design to avoid inflexible long-term commitments or excessive dependence on a single supplier.

 

Conclusion

The U.S. Diagnostic Imaging Devices Market Size & Share is positioned for sustained expansion from USD 14.85 billion in 2025 to USD 27.36 billion by 2035, supported by a 6.30% CAGR during the forecast period. The market’s long-term strength is grounded in the clinical indispensability of imaging, a large installed base, population aging, high cancer and stroke burden, outpatient expansion, and the need to replace systems that no longer meet workflow, cybersecurity, or economic requirements.

The most attractive growth opportunities will be found in photon-counting and spectral CT, AI-enabled reconstruction, virtually helium-free MRI, digital PET, advanced breast imaging, portable ultrasound, mobile imaging, and enterprise fleet orchestration. X-ray, conventional CT, 1.5T MRI, and cart-based ultrasound will remain the largest sources of baseline demand, but value growth will increasingly depend on systems that improve productivity and create new clinical capability. The best-performing manufacturers will demonstrate not only image quality but also shorter scan times, fewer repeats, lower dose, easier operation, higher uptime, and lower lifecycle cost.

Regional opportunity will remain led by the South because of population scale, disease burden, and health-system expansion. The West will gain share through rapid population growth and early adoption of advanced technology. The Northeast will remain the most research-intensive and premium market, while the Midwest will provide stable replacement demand and strong enterprise relationships. California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, New Jersey, Tennessee, Virginia, Washington, and Minnesota will be especially important state markets.

 

TABLE OF CONTENT

1. U.S. Diagnostic Imaging Devices Market: Market Introduction & Context
1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Diagnostic Imaging Device Manufacturers
1.6.2. Detector, Magnet, X-ray Tube, Transducer, Component and Contract Manufacturing Suppliers
1.6.3. Hospitals, Academic Medical Centers and Integrated Delivery Networks
1.6.4. Diagnostic Imaging Centers, Radiology Groups and Teleradiology Networks
1.6.5. Specialty Clinics, Ambulatory Surgery Centers, Urgent Care and Point-of-Care Users
1.6.6. Group Purchasing Organizations, Distributors, Leasing, Refurbishment and Service Partners
1.6.7. Payers, Regulators, Radiologists, Technologists and Clinical Decision-Makers
What this section provides: This section defines the market boundary, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. diagnostic imaging devices market is measured and validated.

2. U.S. Diagnostic Imaging Devices Market: Executive Summary
2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
What this section provides: This section gives decision-makers a concise view of market size, growth direction, modality-level demand, competitive intensity, replacement-cycle momentum, and priority opportunity areas.

3. U.S. Diagnostic Imaging Devices Market: Market Dynamics & Outlook
3.1. Drivers and Their Impact Analysis
3.1.1. Rising Chronic Disease, Cancer, Cardiovascular and Neurological Imaging Demand
3.1.2. Aging Installed Base and Hospital Imaging Fleet Replacement Cycles
3.1.3. Expansion of Outpatient, Emergency, Bedside and Point-of-Care Imaging
3.1.4. Adoption of AI-Enabled Acquisition, Reconstruction, Triage and Workflow Automation
3.1.5. Growth in Screening, Precision Diagnosis and Image-Guided Clinical Pathways
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost and Total Cost of Ownership
3.2.2. Radiologist and Imaging Technologist Workforce Constraints
3.2.3. Reimbursement Pressure, Prior Authorization and Utilization Management
3.2.4. Service, Helium, Magnet, Detector and X-ray Tube Supply Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. Photon-Counting, Spectral and Dual-Energy CT Adoption
3.3.2. Low-Field, Wide-Bore, Open and Portable MRI Expansion
3.3.3. Handheld and Point-of-Care Ultrasound Penetration
3.3.4. Remote Scanning, Cloud Orchestration and Enterprise Imaging Standardization
3.3.5. Mobile Imaging, Rural Access and Distributed Diagnostic Networks
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics and Modality Throughput Analysis
3.7. Hospital Capital Procurement, Leasing and Replacement Behavior Analysis
What this section provides: This section explains the clinical, commercial, reimbursement, workforce, technology, and operational forces shaping imaging demand, helping clients evaluate upside opportunities and execution risks.

4. U.S. Diagnostic Imaging Devices Market: Market Environment & Industry Analysis
4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution and Refurbished Equipment Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region and Modality, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, Enterprise Imaging and Connected Radiology
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework and Software-as-a-Medical-Device Analysis
4.8. CMS Reimbursement, Coverage and Site-of-Service Landscape
4.9. Import/Export Restrictions, Tariff and Component Sourcing Impact
4.10. Government Screening, Rural Health and Public Health Imaging Initiatives
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee and Capital Budget Decision Framework
4.13. Cybersecurity, DICOM, HL7/FHIR and Cloud Interoperability Requirements
What this section provides: This section gives clients a complete view of regulation, reimbursement, pricing, supply chains, interoperability, digital adoption, capital budgeting, and external forces influencing the U.S. diagnostic imaging equipment industry.

5. U.S. Diagnostic Imaging Devices Market – By Product Type
5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. X-ray and Fluoroscopy Systems
5.1.2.1. Fixed Digital Radiography Systems
5.1.2.2. Mobile and Portable X-ray Systems
5.1.2.3. Fluoroscopy and General-Purpose C-arm Systems
5.1.2.4. Digital Detectors and Major System Upgrades
5.1.3. Computed Tomography Systems
5.1.3.1. Conventional Multislice CT Systems
5.1.3.2. High-Slice and Dual-Source CT Systems
5.1.3.3. Spectral and Dual-Energy CT Systems
5.1.3.4. Photon-Counting CT Systems
5.1.3.5. Mobile and Point-of-Care CT Systems
5.1.4. Magnetic Resonance Imaging Systems
5.1.4.1. 1.5 Tesla MRI Systems
5.1.4.2. 3 Tesla MRI Systems
5.1.4.3. Low-Field, Open and Wide-Bore MRI Systems
5.1.4.4. Ultra-High-Field and Research MRI Systems
5.1.4.5. MRI Coils, Software and Major Platform Upgrades
5.1.5. Ultrasound Systems
5.1.5.1. Cart-Based Ultrasound Systems
5.1.5.2. Compact and Portable Ultrasound Systems
5.1.5.3. Handheld and Pocket Ultrasound Systems
5.1.5.4. 3D/4D, Doppler, Elastography and Advanced Ultrasound Platforms
5.1.6. Nuclear Imaging and PET/SPECT Systems
5.1.6.1. PET/CT Systems
5.1.6.2. SPECT/CT Systems
5.1.6.3. Standalone PET and SPECT Systems
5.1.6.4. PET/MRI and Advanced Quantitative Molecular Imaging Systems
5.1.7. Mammography and Breast Imaging Systems
5.1.7.1. Full-Field Digital Mammography Systems
5.1.7.2. Digital Breast Tomosynthesis Systems
5.1.7.3. Contrast-Enhanced Mammography Systems
5.1.7.4. Automated Breast Ultrasound and Adjunct Breast Imaging Systems
What this section provides: This section identifies the imaging modalities and system categories expected to generate the largest revenue contribution, strongest replacement demand, and highest technology-led growth through 2035.

6. U.S. Diagnostic Imaging Devices Market – By Application
6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Oncology Imaging
6.1.2.1. Cancer Screening and Early Detection
6.1.2.2. Tumor Characterization, Staging and Treatment Response Assessment
6.1.2.3. Image-Guided Biopsy and Interventional Oncology Planning
6.1.3. Cardiovascular Imaging
6.1.3.1. Coronary and Cardiac CT Imaging
6.1.3.2. Cardiac MRI Imaging
6.1.3.3. Echocardiography and Vascular Ultrasound
6.1.3.4. Nuclear Cardiology Imaging
6.1.4. Neurology Imaging
6.1.4.1. Stroke, Trauma and Emergency Neuroimaging
6.1.4.2. Neurodegenerative Disease Imaging
6.1.4.3. Epilepsy, Functional and Advanced Brain Imaging
6.1.5. Orthopedic and Musculoskeletal Imaging
6.1.5.1. Trauma and Fracture Imaging
6.1.5.2. Spine, Joint and Degenerative Disease Imaging
6.1.5.3. Sports Medicine and Soft-Tissue Imaging
6.1.6. Women’s Health Imaging
6.1.6.1. Breast Screening and Diagnostic Imaging
6.1.6.2. Obstetric and Fetal Imaging
6.1.6.3. Gynecological and Pelvic Imaging
6.1.7. Emergency, Trauma and Acute Care Imaging
6.1.7.1. Emergency Department and Trauma Imaging
6.1.7.2. Intensive Care and Bedside Imaging
6.1.7.3. Intraoperative, Urgent Care and Rapid Diagnostic Imaging
What this section provides: This section helps clients understand demand by clinical use case and prioritize applications with high scan volumes, strong reimbursement relevance, urgent workflow needs, and significant modality innovation.

7. U.S. Diagnostic Imaging Devices Market – By End User
7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic and Tertiary Care Hospitals
7.1.2.2. Community and Regional Hospitals
7.1.2.3. Federal, Veterans and Military Health Facilities
7.1.3. Diagnostic Imaging Centers
7.1.3.1. Independent Outpatient Imaging Centers
7.1.3.2. Hospital-Owned Outpatient Imaging Networks
7.1.4. Specialty Clinics and Ambulatory Surgery Centers
7.1.4.1. Orthopedic, Cardiology, Oncology and Neurology Clinics
7.1.4.2. Women’s Health and Breast Imaging Centers
7.1.4.3. Ambulatory Surgery and Image-Guided Procedure Centers
7.1.5. Physician Offices, Urgent Care and Point-of-Care Settings
7.1.5.1. Primary Care and Multispecialty Physician Practices
7.1.5.2. Urgent Care and Retail Health Facilities
7.1.5.3. Emergency Medical, Mobile and Community Care Settings
7.1.6. Academic, Government and Research Institutions
7.1.6.1. Universities and Medical Research Centers
7.1.6.2. Public Health, Government and Translational Imaging Programs
What this section provides: This section explains which care settings and institutional buyers are expected to drive capital purchases, fleet standardization, portable imaging adoption, software upgrades, and service-contract demand.

8. U.S. Diagnostic Imaging Devices Market – By Portability
8.1. Overview
8.1.1. Segment Share Analysis, By Portability, 2025 & 2035 (%)
8.1.2. Fixed Imaging Systems
8.1.2.1. Room-Based X-ray and Fluoroscopy Systems
8.1.2.2. Fixed CT and MRI Systems
8.1.2.3. Fixed Nuclear Imaging and Mammography Systems
8.1.3. Mobile and Transportable Imaging Systems
8.1.3.1. Mobile X-ray and Digital Radiography Systems
8.1.3.2. Mobile CT and MRI Systems
8.1.3.3. Mobile C-arm and Portable Ultrasound Systems
8.1.3.4. Trailer-Based and Shared-Service Mobile Imaging Units
8.1.4. Handheld and Point-of-Care Imaging Systems
8.1.4.1. Handheld and Pocket Ultrasound Devices
8.1.4.2. Compact Specialty and Procedure-Guidance Imaging Devices
What this section provides: This section evaluates how fixed, mobile, transportable, and handheld platforms are changing site-of-care economics, bedside access, rural coverage, emergency workflows, and capital deployment decisions.

9. U.S. Diagnostic Imaging Devices Market – By Technology Architecture
9.1. Overview
9.1.1. Segment Share Analysis, By Technology Architecture, 2025 & 2035 (%)
9.1.2. Digital and Software-Upgradeable Platforms
9.1.2.1. Flat-Panel Detector and Fully Digital Imaging Systems
9.1.2.2. Software-Defined Acquisition and Reconstruction Platforms
9.1.3. AI-Enabled Imaging Systems
9.1.3.1. AI-Assisted Acquisition and Image Reconstruction
9.1.3.2. AI-Based Triage, Detection, Quantification and Decision Support
9.1.3.3. Workflow Automation, Protocoling and Operational Analytics
9.1.4. Spectral, Photon-Counting and Advanced Detector Technologies
9.1.4.1. Dual-Energy and Spectral Imaging
9.1.4.2. Photon-Counting Detector Imaging
9.1.4.3. Digital PET, Solid-State and Advanced Semiconductor Detectors
9.1.5. Hybrid and Quantitative Imaging Platforms
9.1.5.1. PET/CT and SPECT/CT Platforms
9.1.5.2. PET/MRI and Multimodality Fusion Imaging
9.1.5.3. Quantitative Imaging and Biomarker Measurement Platforms
9.1.6. Cloud-Connected and Enterprise-Orchestrated Imaging
9.1.6.1. Remote Operations and Virtual Scanning Support
9.1.6.2. Enterprise Imaging, Cloud Connectivity and Workflow Orchestration
9.1.6.3. Fleet Analytics, Predictive Maintenance and Cybersecurity Management
What this section provides: This section evaluates the technology architectures reshaping image quality, productivity, remote operations, interoperability, upgrade economics, and enterprise purchasing across U.S. imaging networks.

10. U.S. Diagnostic Imaging Devices Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Scan Volume, Installed Base and Hospital Infrastructure Analysis
10.1.4. Regional Reimbursement, Capital Budgeting and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Diagnostic Imaging Device Key Manufacturers, Installed Base, Service and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Diagnostic Imaging Device Key Manufacturers, Installed Base, Service and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Diagnostic Imaging Device Key Manufacturers, Installed Base, Service and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Diagnostic Imaging Device Key Manufacturers, Installed Base, Service and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Portability, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Technology Architecture, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify imaging installed-base concentrations, replacement-cycle hotspots, outpatient expansion markets, modality adoption hubs, and state-level commercial opportunities.

11. U.S. Diagnostic Imaging Devices Market: Competitive Landscape & Company Profiles
11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. GE HealthCare
11.3.2. Siemens Healthineers
11.3.3. Philips Healthcare
11.3.4. Canon Medical Systems USA
11.3.5. Fujifilm Healthcare Americas
11.3.6. Hologic
11.3.7. Carestream Health
11.3.8. Samsung Healthcare and NeuroLogica
11.3.9. United Imaging Healthcare
11.3.10. Shimadzu Medical Systems USA
11.3.11. Konica Minolta Healthcare Americas
11.3.12. Esaote North America
11.3.13. Mindray North America
11.3.14. Agfa HealthCare
11.3.15. Sectra
11.3.16. Butterfly Network
11.3.17. Clarius Mobile Health
11.3.18. EchoNous
11.3.19. iCAD
11.3.20. Aidoc
11.3.21. Nanox
11.3.22. CurveBeam AI
11.3.23. Orthoscan
11.3.24. Ziehm Imaging
11.3.25. Planmeca USA
Note: Each company profile will include company overview, diagnostic imaging portfolio, U.S. installed-base and service strategy, financial positioning, technology pipeline, regulatory updates, partnerships, software capabilities, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, modality and portfolio positioning, installed-base strategy, innovation direction, and strategic intelligence on major diagnostic imaging companies.

12. U.S. Diagnostic Imaging Devices Market: Future Market Outlook, 2026–2035
12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Photon-Counting and Spectral CT Platforms
12.2.2. AI-Assisted Acquisition, Reconstruction and Workflow Automation
12.2.3. Low-Field, Open, Portable and Site-Flexible MRI
12.2.4. Handheld Ultrasound and Distributed Point-of-Care Imaging
12.2.5. Remote Scanning, Cloud Orchestration and Enterprise Imaging Platforms
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
What this section provides: This section prepares clients for future modality shifts, software-led business models, capital replacement cycles, market-structure changes, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Diagnostic Imaging Devices Market: Strategic Recommendations
13.1. Recommendations for Diagnostic Imaging Device Manufacturers
13.2. Recommendations for Hospitals, Health Systems and Imaging Centers
13.3. Recommendations for Investors and Private Equity Firms
13.4. Recommendations for Distributors, Service Providers and Channel Partners
13.5. Recommendations for New Entrants and Startups
13.6. Go-to-Market Strategy Considerations
13.7. Product Positioning, Service Strategy and Portfolio Expansion Guidance
What this section provides: This section converts market intelligence into actionable strategy for growth planning, modality positioning, service-model design, channel expansion, investment decisions, and competitive differentiation.

14. U.S. Diagnostic Imaging Devices Market: Disclaimer
14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Diagnostic Imaging Devices Market: Market Definition and Scope
TABLE 3: U.S. Diagnostic Imaging Devices Market: Research Methodology Framework
TABLE 4: U.S. Diagnostic Imaging Devices Market: Key Assumptions
TABLE 5: U.S. Diagnostic Imaging Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Diagnostic Imaging Devices Market: Stakeholder Analysis
TABLE 7: U.S. Diagnostic Imaging Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Diagnostic Imaging Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Diagnostic Imaging Devices Market: Market Attractiveness Index
TABLE 10: U.S. Diagnostic Imaging Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Diagnostic Imaging Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Diagnostic Imaging Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Diagnostic Imaging Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Diagnostic Imaging Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Diagnostic Imaging Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Diagnostic Imaging Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Diagnostic Imaging Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Diagnostic Imaging Devices Market: Clinical Workflow Economics and Modality Throughput Matrix
TABLE 19: U.S. Diagnostic Imaging Devices Market: Hospital Capital Procurement, Leasing and Replacement Behavior Matrix
TABLE 20: U.S. Diagnostic Imaging Devices Market: PESTEL Analysis
TABLE 21: U.S. Diagnostic Imaging Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Diagnostic Imaging Devices Market: Pricing Trend Analysis by Region and Modality, 2025–2035
TABLE 23: U.S. Diagnostic Imaging Devices Market: Value Chain Analysis
TABLE 24: U.S. Diagnostic Imaging Devices Market: Supply Chain Analysis
TABLE 25: U.S. Diagnostic Imaging Devices Market: Digitalization, Enterprise Imaging and Connected Radiology Impact
TABLE 26: U.S. Diagnostic Imaging Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Diagnostic Imaging Devices Market: FDA Regulatory Framework and Software-as-a-Medical-Device Analysis
TABLE 28: U.S. Diagnostic Imaging Devices Market: CMS Reimbursement, Coverage and Site-of-Service Landscape
TABLE 29: U.S. Diagnostic Imaging Devices Market: Import/Export Restrictions, Tariff and Component Sourcing Impact
TABLE 30: U.S. Diagnostic Imaging Devices Market: Government Screening, Rural Health and Public Health Imaging Initiatives
TABLE 31: U.S. Diagnostic Imaging Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Diagnostic Imaging Devices Market: Hospital Value Analysis Committee and Capital Budget Decision Framework
TABLE 33: U.S. Diagnostic Imaging Devices Market: Cybersecurity, DICOM, HL7/FHIR and Cloud Interoperability Requirements
TABLE 34: U.S. Diagnostic Imaging Devices Market: Product Type Snapshot, 2025
TABLE 35: Segment Dashboard; Definition and Scope, by Product Type
TABLE 36: U.S. Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 37: U.S. Diagnostic Imaging Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 38: U.S. Diagnostic Imaging Devices Market: X-ray and Fluoroscopy Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Diagnostic Imaging Devices Market: Computed Tomography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Diagnostic Imaging Devices Market: Magnetic Resonance Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Diagnostic Imaging Devices Market: Ultrasound Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Diagnostic Imaging Devices Market: Nuclear Imaging and PET/SPECT Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Diagnostic Imaging Devices Market: Mammography and Breast Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Diagnostic Imaging Devices Market: Application Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Application
TABLE 46: U.S. Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 47: U.S. Diagnostic Imaging Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 48: U.S. Diagnostic Imaging Devices Market: Oncology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Diagnostic Imaging Devices Market: Cardiovascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Diagnostic Imaging Devices Market: Neurology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Diagnostic Imaging Devices Market: Orthopedic and Musculoskeletal Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Diagnostic Imaging Devices Market: Women’s Health Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Diagnostic Imaging Devices Market: Emergency, Trauma and Acute Care Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Diagnostic Imaging Devices Market: End User Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by End User
TABLE 56: U.S. Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 57: U.S. Diagnostic Imaging Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 58: U.S. Diagnostic Imaging Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Diagnostic Imaging Devices Market: Diagnostic Imaging Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Diagnostic Imaging Devices Market: Specialty Clinics and Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Diagnostic Imaging Devices Market: Physician Offices, Urgent Care and Point-of-Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Diagnostic Imaging Devices Market: Academic, Government and Research Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Diagnostic Imaging Devices Market: Portability Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by Portability
TABLE 65: U.S. Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 66: U.S. Diagnostic Imaging Devices Market: Segment Share Analysis, by Portability, 2025 & 2035 (%)
TABLE 67: U.S. Diagnostic Imaging Devices Market: Fixed Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Diagnostic Imaging Devices Market: Mobile and Transportable Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Diagnostic Imaging Devices Market: Handheld and Point-of-Care Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Diagnostic Imaging Devices Market: Technology Architecture Snapshot, 2025
TABLE 71: Segment Dashboard; Definition and Scope, by Technology Architecture
TABLE 72: U.S. Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 73: U.S. Diagnostic Imaging Devices Market: Segment Share Analysis, by Technology Architecture, 2025 & 2035 (%)
TABLE 74: U.S. Diagnostic Imaging Devices Market: Digital and Software-Upgradeable Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Diagnostic Imaging Devices Market: AI-Enabled Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Diagnostic Imaging Devices Market: Spectral, Photon-Counting and Advanced Detector Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Diagnostic Imaging Devices Market: Hybrid and Quantitative Imaging Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Diagnostic Imaging Devices Market: Cloud-Connected and Enterprise-Orchestrated Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Diagnostic Imaging Devices Market: Regional Snapshot, 2025
TABLE 80: Segment Dashboard; Definition and Scope, by Region
TABLE 81: U.S. Diagnostic Imaging Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 82: U.S. Diagnostic Imaging Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 83: West Region U.S. Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 84: West Region U.S. Diagnostic Imaging Devices Market: Key Manufacturers, Installed Base, Service and Procurement Ecosystem
TABLE 85: West Region U.S. Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 91: California Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 92: California Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: California Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 95: California Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 96: Washington Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 97: Washington Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 98: Washington Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 100: Washington Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 101: Arizona Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 102: Arizona Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Arizona Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 105: Arizona Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 106: Colorado Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 107: Colorado Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Colorado Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 110: Colorado Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 111: Oregon Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 112: Oregon Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Oregon Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 115: Oregon Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 116: Utah Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 117: Utah Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 118: Utah Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 120: Utah Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 121: Nevada Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 122: Nevada Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Nevada Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 125: Nevada Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 130: New Mexico Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 131: Idaho Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 132: Idaho Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: Idaho Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 135: Idaho Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 136: Montana Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 137: Montana Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: Montana Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 140: Montana Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 145: Wyoming Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 146: Alaska Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 147: Alaska Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 148: Alaska Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 150: Alaska Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 155: Hawaii Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 156: Northeast Region U.S. Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 157: Northeast Region U.S. Diagnostic Imaging Devices Market: Key Manufacturers, Installed Base, Service and Procurement Ecosystem
TABLE 158: Northeast Region U.S. Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 164: New York Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 165: New York Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: New York Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 168: New York Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 173: Massachusetts Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 178: New Jersey Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 183: Pennsylvania Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 188: Connecticut Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 189: Maine Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 190: Maine Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 191: Maine Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 193: Maine Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 194: Vermont Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 195: Vermont Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 196: Vermont Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 198: Vermont Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 203: New Hampshire Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 208: Rhode Island Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 209: Delaware Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 210: Delaware Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 211: Delaware Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 213: Delaware Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 214: South Region U.S. Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 215: South Region U.S. Diagnostic Imaging Devices Market: Key Manufacturers, Installed Base, Service and Procurement Ecosystem
TABLE 216: South Region U.S. Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 222: Texas Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 223: Texas Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 224: Texas Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 226: Texas Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 227: Florida Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 228: Florida Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 229: Florida Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 231: Florida Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 232: Georgia Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 233: Georgia Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 234: Georgia Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 236: Georgia Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 241: North Carolina Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 246: Tennessee Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 251: South Carolina Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 252: Alabama Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 253: Alabama Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 254: Alabama Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 256: Alabama Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 261: Mississippi Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 266: Louisiana Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 271: Arkansas Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 276: Kentucky Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 281: Oklahoma Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 282: Virginia Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 283: Virginia Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 284: Virginia Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 286: Virginia Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 287: Maryland Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 288: Maryland Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 289: Maryland Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 291: Maryland Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 296: West Virginia Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 297: Midwest Region U.S. Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 298: Midwest Region U.S. Diagnostic Imaging Devices Market: Key Manufacturers, Installed Base, Service and Procurement Ecosystem
TABLE 299: Midwest Region U.S. Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 305: Illinois Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 306: Illinois Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: Illinois Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Illinois Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 309: Illinois Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 310: Ohio Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 311: Ohio Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 312: Ohio Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Ohio Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 314: Ohio Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 315: Michigan Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 316: Michigan Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Michigan Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Michigan Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 319: Michigan Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 325: Indiana Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 326: Indiana Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 327: Indiana Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Indiana Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 329: Indiana Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 335: Missouri Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 336: Missouri Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 337: Missouri Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Missouri Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 339: Missouri Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 340: Iowa Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 341: Iowa Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 342: Iowa Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Iowa Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 344: Iowa Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 345: Kansas Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 346: Kansas Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 347: Kansas Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Kansas Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 349: Kansas Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Diagnostic Imaging Devices Market, by Portability, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Diagnostic Imaging Devices Market, by Technology Architecture, 2021–2035 (US$ Billion)
TABLE 365: U.S. Diagnostic Imaging Devices Market: Competitive Landscape Snapshot, 2025
TABLE 366: U.S. Diagnostic Imaging Devices Market: Key Company Market Share Analysis, 2025
TABLE 367: U.S. Diagnostic Imaging Devices Market: Company Positioning Matrix
TABLE 368: U.S. Diagnostic Imaging Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 369: U.S. Diagnostic Imaging Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 370: GE HealthCare: Company Profile
TABLE 371: Siemens Healthineers: Company Profile
TABLE 372: Philips Healthcare: Company Profile
TABLE 373: Canon Medical Systems USA: Company Profile
TABLE 374: Fujifilm Healthcare Americas: Company Profile
TABLE 375: Hologic: Company Profile
TABLE 376: Carestream Health: Company Profile
TABLE 377: Samsung Healthcare and NeuroLogica: Company Profile
TABLE 378: United Imaging Healthcare: Company Profile
TABLE 379: Shimadzu Medical Systems USA: Company Profile
TABLE 380: Konica Minolta Healthcare Americas: Company Profile
TABLE 381: Esaote North America: Company Profile
TABLE 382: Mindray North America: Company Profile
TABLE 383: Agfa HealthCare: Company Profile
TABLE 384: Sectra: Company Profile
TABLE 385: Butterfly Network: Company Profile
TABLE 386: Clarius Mobile Health: Company Profile
TABLE 387: EchoNous: Company Profile
TABLE 388: iCAD: Company Profile
TABLE 389: Aidoc: Company Profile
TABLE 390: Nanox: Company Profile
TABLE 391: CurveBeam AI: Company Profile
TABLE 392: Orthoscan: Company Profile
TABLE 393: Ziehm Imaging: Company Profile
TABLE 394: Planmeca USA: Company Profile
TABLE 395: U.S. Diagnostic Imaging Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 396: U.S. Diagnostic Imaging Devices Market: Disruptive Technologies Impact Matrix
TABLE 397: U.S. Diagnostic Imaging Devices Market: Emerging Business Trends
TABLE 398: U.S. Diagnostic Imaging Devices Market: Business Opportunities for Startups and Existing Players
TABLE 399: U.S. Diagnostic Imaging Devices Market: Investment Prioritization Matrix
TABLE 400: U.S. Diagnostic Imaging Devices Market: Strategic Recommendations for Diagnostic Imaging Device Manufacturers
TABLE 401: U.S. Diagnostic Imaging Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 402: U.S. Diagnostic Imaging Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 403: U.S. Diagnostic Imaging Devices Market: Strategic Recommendations for Distributors, Service and Channel Partners
TABLE 404: U.S. Diagnostic Imaging Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 405: U.S. Diagnostic Imaging Devices Market: Go-to-Market Strategy Considerations
TABLE 406: U.S. Diagnostic Imaging Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 407: U.S. Diagnostic Imaging Devices Market: Scope Limitation
TABLE 408: U.S. Diagnostic Imaging Devices Market: Data Use Limitation
TABLE 409: U.S. Diagnostic Imaging Devices Market: Forecasting Limitation
TABLE 410: U.S. Diagnostic Imaging Devices Market: Legal Disclaimer
TABLE 411: U.S. Diagnostic Imaging Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Diagnostic Imaging Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics and Modality Throughput Framework
FIGURE 11: Hospital Capital Procurement, Leasing and Replacement Decision Framework
FIGURE 12: U.S. Diagnostic Imaging Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Diagnostic Imaging Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: X-ray and Fluoroscopy Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Computed Tomography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Magnetic Resonance Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Ultrasound Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Nuclear Imaging and PET/SPECT Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Mammography and Breast Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Oncology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Cardiovascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Neurology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Orthopedic and Musculoskeletal Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Women’s Health Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Emergency, Trauma and Acute Care Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 32: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Diagnostic Imaging Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Specialty Clinics and Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Physician Offices, Urgent Care and Point-of-Care Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Academic, Government and Research Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Portability Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Portability Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Fixed Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Mobile and Transportable Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Handheld and Point-of-Care Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Architecture Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Architecture Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Digital and Software-Upgradeable Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: AI-Enabled Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Spectral, Photon-Counting and Advanced Detector Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Hybrid and Quantitative Imaging Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Cloud-Connected and Enterprise-Orchestrated Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Diagnostic Imaging Technology Innovation Roadmap
FIGURE 119: Photon-Counting and Spectral CT Adoption Roadmap
FIGURE 120: AI-Enabled Imaging and Workflow Automation Opportunity Map
FIGURE 121: Portable, Mobile and Remote Imaging Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Diagnostic Imaging Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework